HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

South Korea Clears BIOLASE's Laser

Share
By: Zacks Equity Research
November 11, 2011 | Comment(s): 0
Recommended this article (6)

Leading dental laser maker BIOLASE Technology (BLTI - Snapshot Report) has clinched regulatory approval in South Korea to market its new WaterLase iPlus all-tissue dental laser across the Northeast Asian nation.

South Korea, with an estimated 25,000 licensed dentists and 16,000 dental clinics, represents a lucrative market for WaterLase iPlus. More than 1,000 practices in South Korea currently use BIOLASE’s dental lasers.

Waterlase iPlus was launched in the U.S. in early 2011. Besides addressing the key functional needs of laser dentists, the device also doubles the power and cutting speed with unmatched control and versatility for novices as well as experienced users.

The approval of this novel product in South Korea represents another major milestone for BIOLASE as the dental practitioners in that country are high tech-centric and very receptive to laser technology. The company has also recently received regulatory clearances in Russia, Canada and Taiwan to market WaterLase iPlus.

BIOLASE noted that it will commence the formal launch of WaterLase iPlus in Seoul on December 10. The device will be marketed by Seoul-based MJ DMT, the company’s distribution partner in South Korea. MJ DMT has already started taking orders for WaterLase iPlus and commenced an aggressive promotional campaign.

BIOLASE develops and markets lasers and related products for applications in medicine and dentistry. Its key products are dental laser systems that perform a broad spectrum of dental procedures, including cosmetic and complex surgical applications.

BIOLASE’s revenues more than doubled year over year in the third quarter to $13.1 million. The company stated that the healthy growth was mainly attributable to its exit from an exclusive distribution arrangement with Henry Schein (HSIC - Snapshot Report) and return to a direct sales and multi-distributor model.

The company’s WaterLase systems accounted for roughly 63% of total sales in the quarter with the Waterlase iPlus laser contributing the most. The device is shaping up to be a major future growth driver.

Read the full analyst report on HSIC

Read the full analyst report on BLTI

 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
Sell These Stocks Today
Make sure no Zacks #5 Rank "Strong Sell" stocks are lurking in your portfolio. They tend to perform only 1/6th as well as the market!
Get your free Welcome Gifts today*:
 1.  Zacks "Strong Sell" list.
 2.  Our e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 16:19 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center